Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
17998298
DOI
10.1124/dmd.107.018341
PII: S0090-9556(24)01570-8
Knihovny.cz E-zdroje
- MeSH
- antifungální látky farmakologie MeSH
- azoly farmakologie MeSH
- buněčné linie MeSH
- Cercopithecus aethiops MeSH
- cytochrom P-450 CYP3A MeSH
- exprese genu účinky léků MeSH
- hepatocyty účinky léků metabolismus MeSH
- kultivované buňky MeSH
- lidé středního věku MeSH
- lidé MeSH
- messenger RNA metabolismus MeSH
- nádorové buněčné linie MeSH
- pregnanový X receptor MeSH
- promotorové oblasti (genetika) MeSH
- reportérové geny genetika MeSH
- rifampin farmakologie MeSH
- senioři MeSH
- steroidní receptory genetika metabolismus MeSH
- systém (enzymů) cytochromů P-450 genetika metabolismus MeSH
- transfekce MeSH
- zvířata MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antifungální látky MeSH
- azoly MeSH
- CYP3A4 protein, human MeSH Prohlížeč
- cytochrom P-450 CYP3A MeSH
- messenger RNA MeSH
- pregnanový X receptor MeSH
- rifampin MeSH
- steroidní receptory MeSH
- systém (enzymů) cytochromů P-450 MeSH
Azole antifungal drug ketoconazole has recently been demonstrated as an inhibitor of a ligand-induced pregnane X receptor (PXR)-mediated transcriptional regulation of the CYP3A4 gene through disruption of PXR interaction with steroid receptor coactivator (SRC)-1. In contrast, other clotrimazole-derived antifungal agents are known as potent inducers of CYP3A4 through PXR. In the present study, we examined effects of azole antimycotics clotrimazole, ketoconazole, econazole, oxiconazole, miconazole, fluconazole, and itraconazole on PXR-mediated expression of CYP3A4. We investigated individual effects of the tested azoles as well as their action on rifampicin-induced PXR-mediated transactivation and expression of CYP3A4 in LS174T cell line and primary human hepatocytes, their interactions with PXR ligand-binding domain, and azole-mediated recruitment of SRC-1 to PXR. In addition, applying the pharmacodynamic approach and dose-response analysis, we aimed to describe the nature of potential interactions of tested azole antimycotics coadministered with a prototypical PXR ligand rifampicin in transactivation of CYP3A4 gene. We describe additive and antagonistic interactions of partial and full agonists of PXR nuclear receptor in the therapeutic group of azole antimycotics in rifampicin-mediated transactivation of CYP3A4. We show that oxiconazole is a highly efficacious activator of CYP3A4 transactivation, which could be antagonized by rifampicin in a competitive manner. In addition, we show that activation of the CYP3A4 promoter is a complex process, which is not exclusively determined by azole-PXR interactions, and we suggest that the ability of some azoles to affect recruitment of SRC-1 to PXR modulates their net effects in transactivation of CYP3A4 both in the absence or presence of rifampicin.
Citace poskytuje Crossref.org
Dual effects of ketoconazole cis-enantiomers on CYP3A4 in human hepatocytes and HepG2 Cells
Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor
Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene